Articles From: Darden's Director Nominees Mail Letter To Shareholders to Data on GlycoMimetics' Drug Candidate's Potential to Treat Lung Infections Caused by Pseudomonas Aeruginosa to Be Presented at North American Cystic Fibrosis Conference


Letter Highlights Significant Progress on Operating Priorities, Including Olive Garden Brand Renaissance Darden's Director Nominees Are Confident in Darden's Future and Their Ability to Drive Superior Growth and Value Creation - For the Benefit of ALL Darden Shareholders Darden Recommends Shareholders Vote "FOR ALL" on BLUE Proxy Card - the Only Card that Provides for Majority Change and a Balanced Approach of Fresh Perspectives, Continuity and Representation for Starboard Nominees Warns Shareholders that Any Vote on the White Card Could Result in Giving Total Control of the Board to Starboard and Its Nominees ORLANDO, Fla.
Sign-up for Darden's Director Nominees Mail Letter To Shareholders investment picks
Darden Restaurants Inc. (DRI) said same-store sales at its Olive Garden restaurants rose 0.6% in the five-week period to Sept.
Sign-up for Darden's Olive Garden's Sept. same-store sales climb 0.6% investment picks
2014/10/10
By Barbara Kollmeyer, MarketWatch Volatility.
Sign-up for Darkest moment for stocks coming up? And beer and weed, a beautiful thing investment picks
IRVING, Texas , Oct.
Sign-up for Darling Ingredients Inc. -- Bakery Feeds Group Announces Custom Blenders Acquisition investment picks
IRVING, Texas , Sept.
Sign-up for Darling Ingredients Inc. Announces Diamond Green Diesel Commencing Start-Up Process investment picks
Company Names Mary R.
Sign-up for Darling Ingredients Inc. Announces New Appointment To Board Of Directors investment picks
IRVING, Texas , Aug.
Sign-up for Darling Ingredients Inc. Reports On Diamond Green Diesel Incident investment picks
- Net income of $32.8 million or $0.20 per diluted share; Pro Forma Adjusted EBITDA of $158.0 million - Solid performance of the new global business with sharp improvement in USA on a sequential basis - Results include $9.2 million of Non-Cash Adjustments and Acquisition-Related Costs IRVING, Texas , Aug.
Sign-up for Darling Ingredients Inc. Reports Second Quarter 2014 Financial Results investment picks
IRVING, Texas , Aug.
Sign-up for Darling Ingredients to Host Investor -- Analyst Forum investment picks
IRVING, Texas , July 28, 2014 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) announced today that management will participate in the Jefferies 2014 Global Industrials Conference in New York City .
Sign-up for Darling Ingredients to Present at Jefferies 2014 Global Industrials Conference and 34th Annual Canaccord Genuity Growth Conference investment picks
AeroVironment, Inc. (NASDAQ:AVAV) announced the Defense Advanced Research Projects Agency (DARPA) has selected the company and its team of industry leaders to follow its successful phase I concept design effort with a phase II preliminary design for the Tactically Exploited Reconnaissance Node, or Tern.
Sign-up for DARPA Awards AeroVironment Phase II Tern Contract to Develop New Class of Maritime Unmanned Aircraft System investment picks
Rite Aid Corporation (NYSE: RAD) today announced that Darren Karst, a highly experienced retail finance executive, is joining Rite Aid as executive vice president and chief financial officer, effective Aug.
Sign-up for Darren Karst Appointed Rite Aid Executive Vice President and Chief Financial Officer investment picks
CHARLOTTE, Mich.
Sign-up for Daryl Adams Named Chief Operating Officer of Spartan Motors investment picks
Significant program will offer Falcon operators a cost-effective solution to comply with emerging airspace mandates ORLANDO, Fla.
Sign-up for Dassault Selects Gogo Business Aviation FANS Solution investment picks
http://media.marketwire.com/attachments/200805/436326_200pixlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135234&ProfileId=051205&sourceType=1 FRIENDSWOOD, TX --
Sign-up for Data Call Technologies, Inc. Continues to Report Record Sales and Record Operational Profits investment picks
Users can now put big data to work, extending access throughout the organization NASHVILLE, Tenn.
Sign-up for Data Fabric Enabled by Teradata® QueryGrid™ Orchestrates the Analytical Ecosystem investment picks
Clovis Oncology (NASDAQ:CLVS) today announced preliminary Phase 2 results from the ARIEL2 ( A ssessment of R ucaparib I n Ovarian Canc e r Tria l ) study and updated results from the ongoing Phase 1/2 monotherapy study of rucaparib.
Sign-up for Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy investment picks
DANVERS, Mass., Sept.
Sign-up for Data From RECOVER RIGHT Impella RP Trial to be Announced at TCT 2014 investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134546&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Announces New PSV3000 Automated Programming System for Asian Markets investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1152104&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Corporation to Announce Third Quarter 2014 Financial Results on October 30, 2014 investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134835&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Reports Second Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1138043&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O to Present at the Rodman & Renshaw 16th Annual Global Investment Conference investment picks
http://media.marketwire.com/attachments/201004/586398_dataiologo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148682&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O's New PSV3000 Wins Global Technology's Award for Programming investment picks
Front-runner in Managed and Cloud Services for Oracle Technologies and Applications Marks Five-Year Anniversary of Specialized Application Engineering Team and Completes Major Upgrade for Haemonetics Corporation BEDFORD, Mass.
Sign-up for Data Intensity Fortifies Track Record of Success in Oracle EBS R12 Implementations and Upgrades investment picks
Survey of CIOs and IT Decision Makers Highlights Storage and Data Management as a Critical Factor to Operational Success; Points to Software and Active Archive as Growth Opportunities SAN JOSE, Calif.
Sign-up for Data Is Currency Of New Economy, But Most Fail To Unlock Its Full Value; HGST Survey Finds 86% Of Data Center Decision-Makers Surveyed Believe That All Data Has Value investment picks
-- First-Line Use of Brincidofovir for CMV May Preserve Subsequent Therapeutic Options --
Sign-up for Data on Chimerix's Brincidofovir Suggests Favorable Resistance Profile in Adenovirus and Cytomegalovirus (CMV) investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Darden's Director Nominees Mail Letter To Shareholders to Data on GlycoMimetics' Drug Candidate's Potential to Treat Lung Infections Caused by Pseudomonas Aeruginosa to Be Presented at North American Cystic Fibrosis Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices